Recently, Liu et al. discovered that ASF1B functioned as a proto-oncogene to modulate the G2/M phase and regulate the expression of cyclinD1, thereby affecting the occurrence and development of tumors [40], which is consistent with the function of TRIM65 that we explored in renal cancer. This evidence concerns the gene TRIM65 and renal carcinoma.